Publications

Les découvertes réalisées à l’IRIC ont permis des avancées majeures à l’égard de la compréhension du développement du cancer et ouvrent la voie à la mise au point de nouvelles solutions thérapeutiques plus ciblées. Ses publications en sont le reflet. Elles rendent également compte du dynamisme et de la productivité des chercheurs de l’Institut.



Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors.Stallaert W, Christopoulos A, Bouvier MExpert Opin Drug Discov 2011-08-01;6(8):811-25.

PP2A-twins is antagonized by greatwall and collaborates with polo for cell cycle progression and centrosome attachment to nuclei in drosophila embryos.Wang P, Pinson X, Archambault VPLoS Genet. 2011-08-01;7(8):e1002227.

Microcalcifications around a collagen-based breast biopsy marker: complication of biopsy with a percutaneous marking system.Trop I, David J, El Khoury M, Gautier N, Gaboury L, Lalonde LAJR Am J Roentgenol 2011-08-01;197(2):W353-7.

Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).Ramachandran R, Mihara K, Chung H, Renaux B, Lau CS, Muruve DA, DeFea KA, Bouvier M, Hollenberg MDJ. Biol. Chem. 2011-07-15;286(28):24638-48.

PSICQUIC and PSISCORE: accessing and scoring molecular interactions.Aranda B, Blankenburg H, Kerrien S, Brinkman FS, Ceol A, Chautard E, Dana JM, De Las Rivas J, Dumousseau M, Galeota E, Gaulton A, Goll J, Hancock RE, Isserlin R, Jimenez RC, Kerssemakers J, Khadake J, Lynn DJ, Michaut M, O'Kelly G, Ono K, Orchard S, Prieto C, Razick S, Rigina O, Salwinski L, Simonovic M, Velankar S, Winter A, Wu G, Bader GD, Cesareni G, Donaldson IM, Eisenberg D, Kleywegt GJ, Overington J, Ricard-Blum S, Tyers M, Albrecht M, Hermjakob HNat. Methods 2011-07-01;8(7):528-9.

ProteoConnections: a bioinformatics platform to facilitate proteome and phosphoproteome analyses.Courcelles M, Lemieux S, Voisin L, Meloche S, Thibault PProteomics 2011-07-01;11(13):2654-71.

Roles for MSI2 and PROX1 in hematopoietic stem cell activity.Hope KJ, Sauvageau GCurr. Opin. Hematol. 2011-07-01;18(4):203-7.

Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens.Kraljacic BC, Arguello M, Amri A, Cormack G, Borden KLeukemia 2011-07-01;25(7):1197-200.

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.Hassan S, Buchanan M, Jahan K, Aguilar-Mahecha A, Gaboury L, Muller WJ, Alsawafi Y, Mourskaia AA, Siegel PM, Salvucci O, Basik MInt. J. Cancer 2011-07-01;129(1):225-32.

An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme.Ceccarelli DF, Tang X, Pelletier B, Orlicky S, Xie W, Plantevin V, Neculai D, Chou YC, Ogunjimi A, Al-Hakim A, Varelas X, Koszela J, Wasney GA, Vedadi M, Dhe-Paganon S, Cox S, Xu S, Lopez-Girona A, Mercurio F, Wrana J, Durocher D, Meloche S, Webb DR, Tyers M, Sicheri FCell 2011-06-24;145(7):1075-87.

Suivez l'IRIC

Logo UdeM